Lycera Announces Publication of Preclinical Immuno-Oncology Research, Demonstrating that Treatment with … – PR Newswire (press release)
|
Lycera Announces Publication of Preclinical Immuno-Oncology Research, Demonstrating that Treatment with …
PR Newswire (press release) "Maintaining fitness of CAR T-cells or other cell therapy products during their production and the persistence of these cells upon transfer into patients with tumors continue to be challenges in the field of adoptive cell therapy," commented Dr. Paulos … |
